Skip to main content
. Author manuscript; available in PMC: 2008 Jul 1.
Published in final edited form as: Neuropharmacology. 2007 Apr 29;53(1):37–47. doi: 10.1016/j.neuropharm.2007.04.008

Figure 5.

Figure 5

Evidence for tonic activation kainate receptors. (A) Specimen records of mEPSCs in a pyramidal cell under control conditions (left) and after bath application of the GluR5 antagonist LY382884 (right). Visual inspection indicates that the frequency of events was reduced by the antagonist. (B,C) summary of effects of LY382884 on frequency and amplitude.